Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
Sonic Healthcare Limited ( (AU:SHL) ) has shared an announcement.
Sonic Healthcare Limited reported robust financial performance for the half-year ended 31 December 2024, with an 8.4% increase in revenue to A$4.7 billion and a 17% rise in net profit to A$237 million. The company highlighted strong organic growth across its laboratory and radiology divisions, particularly in Australia, Germany, and the UK, amid ongoing cost-control measures. Recent acquisitions in Switzerland and Germany are expected to drive future synergies and margin improvements. Sonic’s strategic initiatives, including new contracts and operational efficiencies, are anticipated to support continued earnings growth.
More about Sonic Healthcare Limited
Sonic Healthcare Limited is a leading international healthcare company specializing in laboratory services, radiology, and clinical services. The company operates globally with a strong presence in markets such as Australia, Germany, the UK, the USA, and Switzerland, focusing on high-value specialty testing driven by its Medical Leadership culture.
YTD Price Performance: 4.92%
Average Trading Volume: 870,029
Technical Sentiment Consensus Rating: Sell
Current Market Cap: A$13.61B
See more insights into SHL stock on TipRanks’ Stock Analysis page.
